High Flow Nasal Cannula Market Size to Hit USD 21.87 Bn by 2035

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Product Types
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. High Flow Nasal Cannula Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on High Flow Nasal Cannula Market

5.1. Covid-19: High Flow Nasal Cannula Industry Impact
5.2. High Flow Nasal Cannula Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and High Flow Nasal Cannula Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for High Flow Nasal Cannula Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. High Flow Nasal Cannula Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Ever-increasing number of respiratory disorders
6.1.1.2. Low cost of high-flow nasal cannula compared to low-flow oxygen delivery systems
6.1.2. Market Restraints
6.1.2.1. Low rate of adoption of modern healthcare applications in developing countries
6.1.3. Market Opportunities
6.1.3.1. Increasing popularity and uptake of heated humidified high-flow nasal cannulas

Chapter 7. Global High Flow Nasal Cannula Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. High Flow Nasal Cannula Market Revenue by Market Players
7.1.1.2. High Flow Nasal Cannula Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio, Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End user

Chapter 8. Global High Flow Nasal Cannula Market, By Product Type

8.1. High Flow Nasal Cannula Market, by Product Type
8.1.1. Single Heated Tube
8.1.1.1. Market Revenue and Forecast
8.1.2. Nasal cannula
8.1.2.1. Market Revenue and Forecast
8.1.3. Active humidifier
8.1.3.1. Market Revenue and Forecast
8.1.4. Air blender
8.1.4.1. Market Revenue and Forecast

Chapter 9. Global High Flow Nasal Cannula Market, By End-user

9.1. High Flow Nasal Cannula Market, by End-user
9.1.1. Hospitals and clinics
9.1.1.1. Market Revenue and Forecast
9.1.2. Ambulatory care centers
9.1.2.1. Market Revenue and Forecast
9.1.3. Long-term care centers
9.1.3.1. Market Revenue and Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Forecast

Chapter 10. Global High Flow Nasal Cannula Market, By Application

10.1. High Flow Nasal Cannula Market, by Application
10.1.1. Acute Respiratory Disorder
10.1.1.1. Market Revenue and Forecast
10.1.2. Chronic Respiratory Disorder
10.1.2.1. Market Revenue and Forecast
10.1.3. Acute Heart Failures
10.1.3.1. Market Revenue and Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Forecast

Chapter 11. Global High Flow Nasal Cannula Market, By Sales Channel

11.1. High Flow Nasal Cannula Market, by Sales Channel
11.1.1. Direct Channel
11.1.1.1. Market Revenue and Forecast
11.1.2. Distribution Channel
11.1.2.1. Market Revenue and Forecast

Chapter 12. Global High Flow Nasal Cannula Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Product Type
12.1.2. Market Revenue Forecast by End-user
12.1.3. Market Revenue Forecast by Application
12.1.4. Market Revenue Forecast by Sales Channel
12.1.5. U.S
12.1.5.1. Market Revenue Forecast
12.1.6. Canada
12.1.6.1. Market Revenue Forecast
12.2. Europe
12.2.1. Market Revenue Forecast by Product Type
12.2.2. Market Revenue Forecast by End-user
12.2.3. Market Revenue Forecast by Application
12.2.4. Market Revenue Forecast by Sales Channel
12.2.5. UK
12.2.5.1. Market Revenue Forecast
12.2.6. Germany
12.2.6.1. Market Revenue Forecast
12.2.7. France
12.2.7.1. Market Revenue Forecast
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product Type
12.3.2. Market Revenue Forecast by End-user
12.3.3. Market Revenue Forecast by Application
12.3.4. Market Revenue Forecast by Sales Channel
12.3.5. China
12.3.5.1. Market Revenue Forecast
12.3.6. India
12.3.6.1. Market Revenue Forecast
12.3.7. Japan
12.3.7.1. Market Revenue Forecast
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast
12.4. LATAM
12.4.1. Market Revenue Forecast by Product Type
12.4.2. Market Revenue Forecast by End-user
12.4.3. Market Revenue Forecast by Application
12.4.4. Market Revenue Forecast by Sales Channel
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product Type
12.5.2. Market Revenue Forecast by End-user
12.5.3. Market Revenue Forecast by Application
12.5.4. Market Revenue Forecast by Sales Channel
12.5.5. GCC
12.5.5.1. Market Revenue Forecast
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast

Chapter 13. Company Profiles

13.1. Armstrong Medical Ltd
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio, Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin
13.1.4. Recent Developments and Strategies
13.2. Becton Dickinson, and Company
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio, Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin
13.2.4. Recent Developments and Strategies
13.3. Fisher & Paykel Healthcare Limited
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio, Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin
13.3.4. Recent Developments and Strategies
13.4. Flexicare Medical Ltd
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio, Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin
13.4.4. Recent Developments and Strategies
13.5. Hamilton Medical AG
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio, Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin
13.5.4. Recent Developments and Strategies
13.6. ResMed, Inc.
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio, Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin
13.6.4. Recent Developments and Strategies
13.7. Salter Labs Inc
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio, Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin
13.7.4. Recent Developments and Strategies
13.8. Smiths Medical
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio, Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin
13.8.4. Recent Developments and Strategies
13.9. Teijin Pharma Limited.
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio, Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin
13.9.4. Recent Developments and Strategies
13.10. Teleflex Inc
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio, Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin
13.10.4. Recent Developments and Strategies
13.11. TNI Medical AG
13.11.1. Company Overview, Business Information, Regional Presence
13.11.2. Product Portfolio, Analysis
13.11.2.1. Product Details, Specification, Application
13.11.3. Revenue, Price, and Gross Margin
13.11.4. Recent Developments and Strategies
13.12. Vapotherm Inc.
13.12.1. Company Overview, Business Information, Regional Presence
13.12.2. Product Portfolio, Analysis
13.12.2.1. Product Details, Specification, Application
13.12.3. Revenue, Price, and Gross Margin
13.12.4. Recent Developments and Strategies

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The Nasal Cannula (NC) is a system used to provide extra oxygen to a patient or adult in need of respiratory assistance. The nasal cannula contains a lightweight tube, which then divides into two prongs, these separate prongs are placed in the patients' nostrils, from which a mixture of air and oxygen flows.

Answer : The global high flow nasal cannula market size was valued at USD 8.21 billion in 2025 and is predicted to reach USD 21.87 billion by the end of 2035.

Answer : The global high flow nasal cannula market is expected to grow at a CAGR of 10.29% between forecast period 2026 to 2035.

Answer : The global high flow nasal cannula market growth is driven by growing incidences of asthma and COPD across the globe, low cost of high-flow nasal cannula compared to low-flow oxygen delivery systems, growing geriatric population and launch of advanced products by key operating players in the target industry.

Answer : Acute respiratory disorder application is anticipated to dominate the target market by application during the forecast period 2026-2035. Growing demand for high flow nasal cannula in order to treat acute respiratory disorders worldwide is propelling growth of the segment.